Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Patent Ductus Arteriosus.

Therrien1, Connelly, Webb

  • 1University of Toronto Congenital Cardiac Centre for Adults, The Toronto Hospital, 200 Elizabeth Street, 12 EN 213, Toronto, Ontario M5G 2C4, Canada.

Current Treatment Options in Cardiovascular Medicine
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

(I) Abscess and Sinus over the Lower Part of the Sacrum.

Proceedings of the Royal Society of Medicine·2009
Same author

A Secondary beta Deuterium Kinetic Isotope Effect in the Chorismate Synthase Reaction.

Bioorganic chemistry·2001
Same author

BJS and the blitz

The British journal of surgery·2000
Same author

Crystalloid or colloid for resuscitation. Are we any the wiser?

Critical care (London, England)·2000
Same author

What does robotics offer animal behaviour?

Animal behaviour·2000
Same author

Research methods in human cardiovascular pharmacology

British journal of clinical pharmacology·2000
Same journal

An Update on the Role of Renal Artery Denervation in the Treatment of Hypertension.

Current treatment options in cardiovascular medicine·2026
Same journal

Advancements and Challenges in Contemporizing Care for Adult Patients with Congenital Heart Disease and Advanced Heart Failure: An Update on Application of Modern Heart Failure Technologies.

Current treatment options in cardiovascular medicine·2026
Same journal

Evolving Decongestion Strategies in the Management of Acute Heart Failure.

Current treatment options in cardiovascular medicine·2025
Same journal

Advanced Electroanatomic Mapping: Current and Emerging Approaches.

Current treatment options in cardiovascular medicine·2025
Same journal

Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets.

Current treatment options in cardiovascular medicine·2025
Same journal

Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.

Current treatment options in cardiovascular medicine·2025
See all related articles

Transcatheter device closure is a safe and effective option for adults with patent ductus arteriosus (PDA). This minimally invasive approach offers comparable long-term results to surgery, with faster recovery and less scarring.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Adult Congenital Heart Disease

Background:

  • Patent ductus arteriosus (PDA) closure is typically recommended for adults without pulmonary hypertension.
  • Transcatheter device closure offers advantages over surgery, including avoiding general anesthesia, surgical incisions, and prolonged recovery.

Purpose of the Study:

  • To review the efficacy and safety of transcatheter device closure for PDA in adults.
  • To compare device closure with surgical closure regarding success rates, complications, and long-term outcomes.

Main Methods:

  • Review of established efficacy and safety data for transcatheter device closure of PDA in adults over the past 20 years.
  • Comparison of immediate and late closure rates, and reintervention rates between device and surgical closure.

Related Experiment Videos

Main Results:

  • Transcatheter device closure has established efficacy and safety in adults.
  • While immediate success rates may be lower than surgery, transcatheter reintervention effectively addresses residual shunts.
  • Late complete closure rates are similar between device and surgical closure, though the significance of silent residual shunts remains unclear.

Conclusions:

  • Transcatheter device closure is preferred for most adult PDAs, reserving surgery for larger ducts.
  • The choice of closure method should consider available resources and expertise.
  • Minimally invasive surgical techniques show promise but require further evaluation.